The Improved Experience You’ve Been Waiting For!
Discover the refreshed menu, enjoy the custom dashboard, and make use of the powerful stock screener to enhance your investment approach.
Explore Now
China Healthwise Holdings Ltd (0348:HK) Stock Forecast
Alert
Its only available to paid users.
N/A
Based on the China Healthwise Holdings Ltd stock forecast from 0 analysts, the average analyst target price for China Healthwise Holdings Ltd is not available over the next 12 months. China Healthwise Holdings Ltd’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of China Healthwise Holdings Ltd is Slightly Bearish, which is based on 4 positive signals and 6 negative signals. At the last closing, China Healthwise Holdings Ltd’s stock price was HKD 0.053. China Healthwise Holdings Ltd’s stock price has changed by -10.17% over the past week, -5.36% over the past month and -28.38% over the last year.
No recent analyst target price found for China Healthwise Holdings Ltd
No recent average analyst rating found for China Healthwise Holdings Ltd
Company Overview China Healthwise Holdings Ltd
China Healthwise Holdings Limited, an investment holding company, sells Chinese health products in Hong Kong and The People's Republic of China. The company operates through three segments: Chinese Health Products, Money Lending Business, and Investment in Financial Instruments. It sells Chinese and other pharmaceutical products, health products, ginseng, and dried seafood products to wholesalers and retailers. The company sells Chinese health products online. In addition, it provides loans; and invests in financial instruments. The company was formerly known as Haier Healthwise Holdings Limited and changed its name to China Healthwise Holdings Limited in January 2017. China Healthwise Holdings Limited was incorporated in 1997 and is headquartered in Central, Hong Kong. Address: West Tower, Central, Hong Kong Read Less
China Healthwise Holdings Limited, an investment holding company, sells Chinese health products in Hong Kong and The People's Republic of China. The company operates through three segments: Chinese Health Products, Money Lending Business, and Investment in Financial Instruments. ...Read More
Frequently Asked Questions About China Healthwise Holdings Ltd (0348:HK) Stock
Stock Target Advisor's fundamental analysis for China Healthwise Holdings Ltd's stock is Slightly Bearish.
Unfortunately we do not have enough data on 0348:HK's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on 0348:HK's stock to indicate what its average analyst target is.
0348:HK stock's Price/Earning ratio is 4.02.
Our analysis grades 0348:HK stock's Price / Earning ratio at A+. This means that 0348:HK stock's Price/Earning ratio is above 0% of the stocks in the Pharmaceutical Retailers sector in the HK exchange.
Based on this 0348:HK may be undervalued for its sector.
The last closing price of 0348:HK's stock was HKD 0.05.
The most recent market capitalization for 0348:HK is HKD 0.04B.
Unfortunately we do not have enough analyst data on 0348:HK's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains China Healthwise Holdings Ltd's stock.
As per our most recent records China Healthwise Holdings Ltd has 100 Employees.
China Healthwise Holdings Ltd's registered address is West Tower, Central, Hong Kong.
You can get more information about it from China Healthwise Holdings Ltd's website at https://www.healthwisehk.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Underpriced compared to earnings
The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
High Gross Profit to Asset Ratio
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for 0348:HK !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
